- Home
- ORKA vs CRNC Comparison
ORKA vs CRNC Comparison
Compare ORKA & CRNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORKA
- CRNC
- Stock Information
- Founded
- ORKA 2004
- CRNC 2020
- Country
- ORKA United States
- CRNC United States
- Employees
- ORKA N/A
- CRNC N/A
- Industry
- ORKA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- CRNC EDP Services
- Sector
- ORKA Health Care
- CRNC Technology
- Exchange
- ORKA Nasdaq
- CRNC Nasdaq
- Market Cap
- ORKA 580.3M
- CRNC 552.3M
- IPO Year
- ORKA N/A
- CRNC N/A
- Fundamental
- Price
- ORKA $15.44
- CRNC $11.04
- Analyst Decision
- ORKA Strong Buy
- CRNC Hold
- Analyst Count
- ORKA 9
- CRNC 5
- Target Price
- ORKA $40.38
- CRNC $10.20
- AVG Volume (30 Days)
- ORKA 142.1K
- CRNC 2.8M
- Earning Date
- ORKA 08-11-2025
- CRNC 08-06-2025
- Dividend Yield
- ORKA N/A
- CRNC N/A
- EPS Growth
- ORKA N/A
- CRNC N/A
- EPS
- ORKA N/A
- CRNC N/A
- Revenue
- ORKA N/A
- CRNC $245,947,000.00
- Revenue This Year
- ORKA N/A
- CRNC N/A
- Revenue Next Year
- ORKA N/A
- CRNC $7.31
- P/E Ratio
- ORKA N/A
- CRNC N/A
- Revenue Growth
- ORKA N/A
- CRNC N/A
- 52 Week Low
- ORKA $5.49
- CRNC $2.37
- 52 Week High
- ORKA $52.32
- CRNC $27.50
- Technical
- Relative Strength Index (RSI)
- ORKA 59.14
- CRNC 56.02
- Support Level
- ORKA $14.10
- CRNC $10.07
- Resistance Level
- ORKA $15.76
- CRNC $13.54
- Average True Range (ATR)
- ORKA 1.12
- CRNC 0.87
- MACD
- ORKA 0.04
- CRNC 0.06
- Stochastic Oscillator
- ORKA 83.71
- CRNC 51.83
About ORKA Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its lead program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. The company's co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, psoriatic arthritis (PsA), and other conditions. These programs each bind their respective targets at high affinity and incorporate half-life extension technology to increase exposure and decreasing dosing frequency.
About CRNC Cerence Inc.
Cerence Inc is a United States-based software company. It is involved in developing mobility-based solutions for drivers and their cars. The customers include all automobile original equipment manufacturers, or OEMs, or their tier 1 suppliers. The company's revenue is generated by selling software licenses and cloud-connected services. Geographically, it derives a majority of its revenue from the United States and also has a presence in Other Americas; Germany; Other Europe, the Middle East, Africa; Japan, and Other Asia-Pacific.